Hansa Medical's Rights Issue Oversubscribed
4/11/2014 7:58:28 AM
Hansa Medical’s rights issue with preferential rights has been subscribed at 137
percent of which 99 percent was subscribed through preferential rights. The
rights issue comprises 3.7 million shares at SEK 10 per share, which brings SEK
37 million to the company before issue expenses. The capital will be used for
Phase II-studies with the drug candidate IdeS during 2014 and 2015.
An extraordinary general meeting held on March 5, 2014, resolved to carry
through a rights issue of at the most 3 704 229 shares with preferential rights
at SEK 10 per share. The subscription period for the offer was between March 25
and April 8.
Help employers find you! Check out all the jobs and post your resume.
comments powered by